Medical News Podcast

Andrea J. Singer, MD, FACP, CCD and Michael R. McClung, MD review the preservation of bone health in perimenopausal women, with a particular focus on the role of hormone therapy and how the interplay of hormonal, lifestyle, and genetic factors is key to developing effective prevention and treatment strategies.

A Texas child's measles-related death, the first in the U.S. since 2015, highlights rising cases amid declining vaccination rates. AstraZeneca's Serena 6 trial found camizestrant, delayed disease progression in HR-positive HER2-negative breast cancer. A BMJ study found no link between GLP-1 receptor agonists and increased suicidality in diabetes patients. The CDC reports an 80% decline in high-ris...

Dr. Andrew Budson discusses the relationship between consciousness and memory, proposing that consciousness evolved as part of the memory system. He explains how unconscious processes drive much of our decision-making, with consciousness acting as a memory-based guide to influence behavior. He highlights the role of attention in memory retention and how false memories, particularly in Alzheimer's...

This podcast reports a severe flu season, with hospitalizations exceeding previous years and rising pediatric flu deaths. A Texas measles outbreak, mainly in unvaccinated children, has reached nearly 60 cases, with more in New Mexico, highlighting vaccine decline risks. Research finds moderate to vigorous leisure activity lowers type 2 diabetes risk, while strenuous work activity does not. A UCLA...

Drs. Tiffany A. Traina and Claudine Isaacs discuss how they approach HER2+ early breast cancer treatment planning and which patients can take advantage of de-escalation.

Drs. Traina and Isaacs share how they determine which patients are appropriate for neoadjuvant therapies and how to address residual disease, as well as potential treatment toxicities.

Measles cases are rising in Texas and New Mexico, with most infections occurring in unvaccinated individuals and public health officials warning of further spread. A new study in JAMA Psychiatry found that semaglutide significantly reduces alcohol craving and heavy drinking, suggesting a potential new treatment for alcohol use disorder. Research confirms that self-sampling for HPV is as effective...

Professor Alexander Jensen discusses parental favoritism and its impact on family dynamics, highlighting that both mothers and fathers tend to favor daughters, potentially due to social and evolutionary factors. The study suggests that children who receive less favorable treatment may experience negative mental health and behavioral outcomes, including increased risk-taking and lower self-esteem....

This podcast features Marlie Tondac, the lead author of a study on learning and attention in young children finding that children aged 7 to 9 learn differently from adults; they absorb information more generally from their environment, regardless of specific tasks or goals. This "sponge-like" learning suggests that children benefit from immersive and engaging environments rather than structured, t...

A study in The Journal of Urology highlighted the potential of the MyProstateScore 2.0 (MPS2) urine test to reduce unnecessary prostate biopsies by up to 42%. A study in JAMA Neurology found that certain headache disorders, such as migraine and tension-type headaches, are associated with a higher risk of suicide attempts and deaths compared to the general population. A phase 3 trial in The New Eng...

A new phase 3 trial demonstrated that adding nivolumab to adjuvant chemotherapy significantly improves outcomes for patients with ER-positive HER2-negative breast cancers. Heavy lifetime cannabis use was associated with reduced brain activity in areas responsible for working memory, suggesting potential long-term cognitive impacts. A study found that EMS clinicians wearing ballistic vests experien...

Drs. Solomon and Swigris review how they discuss lung transplantation with patients with ILDs, as well their philosophies of addressing end-of-life issues and the use of opioids in managing symptoms in these patients.

A study in NEJM shows that abelacimab, a fully human monoclonal antibody targeting factor XI, significantly reduces bleeding risk compared to rivaroxaban in atrial fibrillation patients, suggesting a safer alternative for stroke prevention. Data from JAMA Health Forum reveals growing consolidation of primary care practices by hospitals and private equity firms, driving up healthcare costs without...

Drs. Solomon and Swigris focus on the importance of managing comorbidities and addressing treatment-related adverse events, such as GERD and mood disorders, in patients with ILDs to improve quality of life. Pulmonary rehabilitation is also emphasized as a vital component of care for these patients.

Drs. Solomon and Swigris discuss how the treatment of ILDs demands a personalized approach based on the underlying cause and progression of the condition. They explore therapeutic options, including antifibrotic agents and immunosuppressive therapies.

Joshua Solomon, MD and Jeff Swigris, DO discuss ILDs, a group of conditions marked by lung inflammation and fibrosis. They explore classifications, common causes, and advancements in understanding of these disorders to support effective diagnosis and management.

This discussion emphasizes the importance of risk mitigation strategies and practical tips for implementing oral immunotherapy (OIT) in clinical practice. Key points include ensuring adult supervision during dosing, adhering to safe dosing rules to minimize allergic reactions, and maintaining close communication with healthcare providers for adjustments or emergencies. The conversation highlights...

A study in Neurology links high intake of processed red meat to an increased risk of dementia and cognitive decline, with dietary changes showing protective effects. Research in the Journal of Arthroplasty highlights that COVID-19 infection within six weeks before knee surgery significantly raises the risk of venous thromboembolism. Wearable devices, such as Apple Watch and Fitbit, can predict inf...

In this discussion, Dr. Anagnostou and Dr. Greenhot review key elements for informed consent in oral immunotherapy (OIT), emphasizing the benefits, risks, and outcomes of the treatment. They highlight OIT's ability to increase allergen tolerance thresholds, while acknowledging potential risks like dose-related reactions and rare conditions such as eosinophilic gastrointestinal disorders. Alternati...

Aikaterini Anagnostou, MD (Hons), MSc, PhD and Matthew Greenhawt, MD, MBA, MSc discuss the process of preparing patients for oral immunotherapy (OIT). This first part of a 3-part video highlights the development and findings of the first International Delphi Consensus Panel on preparing patients for oral immunotherapy (OIT). Experts created a standardized checklist and consent framework to guide c...

Tejas Patil, MD and Sami Diab, MD discuss the pivotal role HER2 positivity plays in lung cancer including the challenges faced by clinicians in testing for HER2. They discuss topics in sequencing, next generation testing, and liquid biopsies as well as challenges of testing in tissue-efficient manner.

Drs. Isaacs and Traina share insights from the 2024 San Antonio Breast Symposium, covering the MARGOT trial, survival impacts of risk-reducing surgeries in young BRCA carriers, and outcomes of delaying surgery in operable breast cancer.

Claudine Isaacs, MD and Tiffany A. Traina, MD, FASCO share their insights from the 2024 San Antonio Breast Cancer Symposium on the TOUCH trial, DTP trial, and data on SHR-A1811 in HER2+ early breast cancer.

In this episode, a study shows that private equity acquisition of hospitals is linked to declines in patient care experience, with significant drops in ratings and staff responsiveness. The episode also discusses a strong link between hearing loss and increased risk of Parkinson’s disease, suggesting that early auditory health management may play a role in mitigating symptoms. Finally, U.S. medica...

Drs. Komrokji and Kuykendall review the evolution of clinical trial endpoints in myelofibrosis studies. They discuss traditional measures of disease control, such as spleen volume reduction and hematologic response, as well as expanded endpoints that reflect the biological and symptomatic aspects of myelofibrosis.